TY - JOUR
T1 - Regulatory functions of natural killer cells in multiple sclerosis
AU - Gross, Catharina C.
AU - Schulte-Mecklenbeck, Andreas
AU - Wiendl, Heinz
AU - Marcenaro, Emanuela
AU - de Rosbo, Nicole Kerlero
AU - Uccelli, Antonio
AU - Laroni, Alice
PY - 2016/1/1
Y1 - 2016/1/1
N2 - There is increasing evidence that natural killer (NK) cells exhibit regulatory features. Among them, CD56bright NK cells have been suggested to play a major role in controlling T cell responses and maintaining homeostasis. Dysfunction in NK cell-mediated regulatory features has been recently described in untreated multiple sclerosis (MS), suggesting a contribution to MS pathogenesis. Moreover, biological disease-modifying treatments effective in MS apparently enhance the frequencies and/or regulatory function of NK cells, further pointing toward an immunoprotective role of NK cells in MS. Here, we summarize the current knowledge on the regulatory functions of NK cells, based on their interactions with other cells belonging to the innate compartment, as well as with adaptive effector cells. We review the more recent data reporting disruption of NK cell/T cell interactions in MS and discuss how disease-modifying treatments for MS affect NK cells.
AB - There is increasing evidence that natural killer (NK) cells exhibit regulatory features. Among them, CD56bright NK cells have been suggested to play a major role in controlling T cell responses and maintaining homeostasis. Dysfunction in NK cell-mediated regulatory features has been recently described in untreated multiple sclerosis (MS), suggesting a contribution to MS pathogenesis. Moreover, biological disease-modifying treatments effective in MS apparently enhance the frequencies and/or regulatory function of NK cells, further pointing toward an immunoprotective role of NK cells in MS. Here, we summarize the current knowledge on the regulatory functions of NK cells, based on their interactions with other cells belonging to the innate compartment, as well as with adaptive effector cells. We review the more recent data reporting disruption of NK cell/T cell interactions in MS and discuss how disease-modifying treatments for MS affect NK cells.
KW - CD56 NK cells
KW - Innate immune system
KW - Multiple sclerosis
KW - Natural killer cells
KW - Regulatory immune cells
UR - http://www.scopus.com/inward/record.url?scp=85009348062&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85009348062&partnerID=8YFLogxK
U2 - 10.3389/fimmu.2016.00606
DO - 10.3389/fimmu.2016.00606
M3 - Short survey
AN - SCOPUS:85009348062
SN - 1664-3224
VL - 7
JO - Frontiers in Immunology
JF - Frontiers in Immunology
IS - DEC
M1 - 606
ER -